Validation of a novel ELISA for measurement of MDA-LDL in human plasma (original) (raw)
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients
Teresa M Seccia
International Journal of Cardiology, 2013
View PDFchevron_right
Antibodies against oxidized LDL--theory and clinical use
Alexander Lapin
Physiological research / Academia Scientiarum Bohemoslovaca, 2001
View PDFchevron_right
Increased Lipid Peroxidation in LDL from Type-2 Diabetic Patients
Romain Colas, Hubert Vidal, Michel Guichardant
Lipids, 2010
View PDFchevron_right
A Rapid Method for Measurement of the Susceptibility to Oxidation of Low-Density Lipoprotein
Elisabeth Trimble
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1995
View PDFchevron_right
Simple and practical sandwich-type enzyme immunoassay for human oxidatively modified low density lipoprotein using antioxidized phosphatidylcholine monoclonal antibody and antihuman apolipoprotein-B antibody
Ryozo Nagai
Clinical Biochemistry, 2000
View PDFchevron_right
Prooxidant-Antioxidant Balance and Antioxidized LDL Antibody Level Values and Cardiac Function in Patients with Coronary Artery Disease
MaryamSadat Alavi
Cardiology, 2012
View PDFchevron_right
. A. Gözü Pirinccioglu, D. Gökalp, M. Pirinccioglu, G. Kizil and M. Kizil “Malondialdehyde (MDA) and Protein Carbonyl (PCO) Levels As Biomarkers of Oxidative Stress in Subjects with Familial Hypercholesterolemia” Clinical Biochemistry, 43 (15), 1220-1224 (2010).
Murat Kızıl
View PDFchevron_right
A simple method to assess the oxidative susceptibility of low density lipoproteins
silvina molinuevo
BMC Clinical Pathology, 2001
View PDFchevron_right
Importance of the lipid peroxidation biomarkers and methodological aspects FOR malondialdehyde quantification
Clovis Paniz
Química Nova, 2009
View PDFchevron_right
Auto-antibodies against oxidized low density lipoproteins in systemic diseases
Anton Stalenhoef, Eric Van Bommel
Atherosclerosis, 1995
View PDFchevron_right
A microassay to assess the oxidative resistance of low-density lipoproteins
József Balla
1998
View PDFchevron_right
Oxidized LDL and its correlation with lipid profile and oxidative stress biomarkers in young healthy Spanish subjects
Maria Sanchez-campillo
Journal of Physiology and Biochemistry, 2010
View PDFchevron_right
Anti-oxidized low-density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers
Isabel Virella-lowell, Gabriel Virella
International journal of clinical & laboratory research, 1993
View PDFchevron_right
Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis
Terho Lehtimäki
2005
View PDFchevron_right
Assessment of lipid per-oxidation and endothelial dysfunction in patients of coronary artery disease
IP Innovative Publication Pvt. Ltd.
IP innovative publication pvt. ltd, 2019
View PDFchevron_right
LDL oxidation in patients with severe carotid atherosclerosis. A study of in vitro and in vivo oxidation markers
Renata Castellano, Germano Melissano
Arteriosclerosis, Thrombosis, and Vascular Biology, 1994
View PDFchevron_right
Anti-oxidized low-density lipoprotein antibody levels are associated with the development of type 2 diabetes mellitus
Dror Harats
European Journal of Clinical Investigation, 2008
View PDFchevron_right
Detection of Oxidized Phospholipid-protein Adducts Using Anti-15-Hydroperoxyeicosatetraenoic Acid-Modified Protein Antibody: Contribution of Esterified Fatty Acid–Protein Adduct to Oxidative Modification of LDL
Yoji Kato
Archives of Biochemistry and Biophysics, 1998
View PDFchevron_right
Screening of Preformed Oxidised Low Density Lipoprotein Isolated by a Polyanion Precipitation Method. Its Correlation with Serum Triglyceride Levels
Julio Bruetman
Pharmacological Research, 1998
View PDFchevron_right
A Novel Immunoassay for Malondialdehyde-Conjugated Low-Density Lipoprotein Measures Dynamic Changes in the Blood of Patients Undergoing Coronary Artery Bypass Graft Surgery
Bao Nguyen
Antioxidants, 2021
View PDFchevron_right
A Study on Malondialdehyde as a Marker of Lipid Peroxidation in Male and Female Patients with Type 2 Diabetes Mellitus
Marya Ahsan
Age (years)
View PDFchevron_right
Increased malondialdehyde levels in coronary heart disease
Mudassir A Khan
JPMA. The Journal of the Pakistan Medical Association, 2000
View PDFchevron_right
CORRELATION BETWEEN LAG TIME OF LDL TO IN VITRO OXIDATION AND IN VIVO OXIDIZED LDL IN THE PATIENTS WITH CORONARY ARTERY DISEASE
hashem nayeri
2008
View PDFchevron_right
In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression
Wulf Palinski
Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
View PDFchevron_right
Inverse relation between levels of anti-oxidized-LDL antibodies and eicosapentanoic acid (EPA)
federico soriguer
British Journal of Nutrition, 2008
View PDFchevron_right